Halozyme Therapeutics
HALO
#2119
Rank
NZ$12.95 B
Marketcap
$105.20
Share price
0.14%
Change (1 day)
56.94%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): NZ$0.93 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.01 Billion. , an increase over its 2023 earnings that were of NZ$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.98 B59.94%
2023 NZ$0.61 B39.94%
2022 NZ$0.44 B0.16%
2021 NZ$0.44 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.15 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.19 Billion216.03%
2015 -NZ$57.25 Million-52.86%
2014 -NZ$0.13 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$95.12 Million169.94%
2011 -NZ$35.24 Million-63.44%
2010 -NZ$96.37 Million-7.19%
2009 -NZ$0.11 Billion15.91%
2008 -NZ$89.58 Million83.89%
2007 -NZ$48.72 Million78.1%
2006 -NZ$27.36 Million16%
2005 -NZ$23.58 Million45.24%
2004 -NZ$16.24 Million682.42%
2003 -NZ$2.08 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$44.46 M-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.52 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.29 B-70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.33 B 1,146.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.10 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$30.97 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA